Terms: = Colorectal cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Prognosis
476 results:
1. Indoxyl sulfate contributes to colorectal cancer cell proliferation and increased EGFR expression by activating AhR and akt.
Ichisaka Y; Yano S; Nishimura K; Niwa T; Shimizu H
Biomed Res; 2024; 45(2):57-66. PubMed ID: 38556263
[TBL] [Abstract] [Full Text] [Related]
2. Predictive value of immediate early response 5 like (IER5L) in the prognosis and immune checkpoint blockade therapy of non-small cell lung cancer patients.
Wang N; Tan X; Cao S; Liu M
Pathol Res Pract; 2024 Apr; 256():155270. PubMed ID: 38552564
[TBL] [Abstract] [Full Text] [Related]
3. prognosis significance and potential association between ALDOA and akt expression in colorectal cancer.
Xu M; Xi S; Li H; Xia Y; Mei G; Cheng Z
Sci Rep; 2024 Mar; 14(1):6488. PubMed ID: 38499636
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of PI3K/akt signaling using BKM120 reduced the proliferation and migration potentials of colorectal cancer cells and enhanced cisplatin-induced cytotoxicity.
Khameneh SC; Sari S; Razi S; Yousefi AM; Bashash D
Mol Biol Rep; 2024 Mar; 51(1):420. PubMed ID: 38483663
[TBL] [Abstract] [Full Text] [Related]
5. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma.
Wang WP; Shi D; Yun D; Hu J; Wang JF; Liu J; Yang YP; Li MR; Wang JF; Kong DL
World J Gastroenterol; 2024 Feb; 30(6):565-578. PubMed ID: 38463028
[TBL] [Abstract] [Full Text] [Related]
6. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/akt/mTOR signaling pathway].
Tao SN; Liu XC; Wang YY; Yang H
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
[No Abstract] [Full Text] [Related]
7. Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer.
Liu H; Zhou D; Liu D; Xu X; Zhang K; Hu R; Xiong P; Wang C; Zeng X; Wang L; Zhang S
Cell Death Dis; 2024 Mar; 15(3):187. PubMed ID: 38443386
[TBL] [Abstract] [Full Text] [Related]
8. CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer.
Lv Q; Zhang Y; Gao W; Wang J; Hu Y; Yang H; Xie Y; Lv Y; Zhang H; Wu D; Hu L; Wang J
Pharmacol Res; 2024 Apr; 202():107126. PubMed ID: 38432446
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic Assessment of colorectal cancer Patients after Laparoscopic Surgery: A Comprehensive Evaluation of the Glasgow Prognostic Score and Fibrinogen-to-Prealbumin Ratio.
Liu B; Qian J; Zhou Y; Chen N; Zhuang H; Wang J; Zhang X; Zhao H
Med Sci Monit; 2024 Feb; 30():e942658. PubMed ID: 38379279
[TBL] [Abstract] [Full Text] [Related]
10. Risk factors affecting patients survival with colorectal cancer in Morocco: survival analysis using an interpretable machine learning approach.
El Badisy I; BenBrahim Z; Khalis M; Elansari S; ElHitmi Y; Abbass F; Mellas N; El Rhazi K
Sci Rep; 2024 Feb; 14(1):3556. PubMed ID: 38346963
[TBL] [Abstract] [Full Text] [Related]
11. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-akt-mTOR pathway and is a therapeutic target.
Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
[TBL] [Abstract] [Full Text] [Related]
12. Role of PAX6, TRPA1, BCL11B, MCOLN2, CUX1, EMX1 in colorectal cancer and osteosarcoma.
Zhang J; Gao Q; Hou S; Chi X; Zheng M; Zhang Q; Shan H; Zhang X; Kang C
Medicine (Baltimore); 2024 Feb; 103(5):e37056. PubMed ID: 38306561
[TBL] [Abstract] [Full Text] [Related]
13. Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced colorectal cancer Patients: An Exploratory Study.
Cayún JP; Cerpa LC; Colombo A; Cáceres DD; Leal JL; Reyes F; Gutiérrez-Cáceres C; Calfunao S; Varela NM; Quiñones LA
Curr Oncol; 2024 Jan; 31(1):274-295. PubMed ID: 38248103
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of preoperative white blood cell to hemoglobin ratio and fibrinogen to albumin ratio in patients with colorectal cancer.
Li K; Yan J; Zhang H; Lu C; Wang W; Guo M; Zhang X; Zhang Z
Medicine (Baltimore); 2024 Jan; 103(3):e37031. PubMed ID: 38241544
[TBL] [Abstract] [Full Text] [Related]
15. Is radiotherapy necessary for upper rectal cancer underwent curative resection? A retrospective study of 363 patients.
Ma Z; Zhou J; Liu K; Chen S; Wu Q; Peng L; Zhao W; Zhu S
Radiat Oncol; 2024 Jan; 19(1):8. PubMed ID: 38238776
[TBL] [Abstract] [Full Text] [Related]
16. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes.
Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H
Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555
[TBL] [Abstract] [Full Text] [Related]
17. ABHD6 suppresses colorectal cancer progression via akt signaling pathway.
Xiong X; Yang C; Jin Y; Zhang R; Wang S; Gan L; Hou S; Bao Y; Zeng Z; Ye Y; Gao Z
Mol Carcinog; 2024 Apr; 63(4):647-662. PubMed ID: 38197491
[TBL] [Abstract] [Full Text] [Related]
18. Occurrence and Risk Factors for Acute Urinary Retention and Urinary Tract Infection in Patients Undergoing Urinary Drainage after colorectal Resection.
Song Z; Yu L; Wu Q; Zhang Y
Arch Esp Urol; 2023 Dec; 76(10):772-779. PubMed ID: 38186070
[TBL] [Abstract] [Full Text] [Related]
19. KLF7 promotes colon adenocarcinoma progression through the PDGFB signaling pathway.
Zhang Z; Jiang X; Li K; Qiao S; Li M; Mei Y; Ding L; Lv Q; Ding Y; Zhao Y; Lv G; Tan G; Yang H; Li G; Gao X; Liu M
Int J Biol Sci; 2024; 20(1):387-402. PubMed ID: 38164176
[TBL] [Abstract] [Full Text] [Related]
20. KLK10 promotes the progression of KRAS mutant colorectal cancer via PAR1-PDK1-akt signaling pathway.
Wu K; Wu B; Yan K; Ding Q; Miao Z
Cell Biol Int; 2024 Apr; 48(4):440-449. PubMed ID: 38115179
[TBL] [Abstract] [Full Text] [Related]
[Next]
